Nis Halland
Nis Halland, Bad Soden DE
Patent application number | Description | Published |
---|---|---|
20100035930 | UREA AND SULFAMIDE DERIVATIVES AS INHIBITORS OF TAFIa - The invention relates to compounds of the formula I | 02-11-2010 |
20100216988 | Regioselective metal catalyzed synthesis of annelated benzimidazoles and azabenzimidazoles - The present invention relates to a process for the regioselective synthesis of compounds of the formula I, | 08-26-2010 |
20100234601 | Transition metal catalyzed synthesis of 2H-indazoles - The present invention relates to a process for the regioselective synthesis of compounds of the formula I, | 09-16-2010 |
20100261900 | Process for the palladium-catalyzed coupling of terminal alkynes with heteroaryl tosylates and heteroaryl benzenesulfonates - A process for the palladium-catalyzed coupling of terminal alkynes with heteroaryl tosylates and heteroaryl benzenesulfonates | 10-14-2010 |
20100261909 | Regioselective copper catalyzed synthesis of benzimidazoles and azabenzimidazoles - The present invention relates to a process for the regioselective synthesis of compounds of the formula I, | 10-14-2010 |
20100261910 | Process for the palladium-catalyzed coupling of terminal alkynes with aryl tosylates - The present invention relates to a process for the regioselective synthesis of compounds of the formula (I), | 10-14-2010 |
Nis Halland, Bad Soden DK
Patent application number | Description | Published |
---|---|---|
20100168429 | Transition metal catalyzed synthesis of N-aminoindoles - The present invention relates to a process for the regioselective synthesis of compounds of the formula I, | 07-01-2010 |
Nis Halland, Frankfurt DE
Patent application number | Description | Published |
---|---|---|
20090203912 | Regioselective palladium catalyzed synthesis of benzimidazoles and azabenzimidazoles - The present invention relates to a process for the regioselective synthesis of compounds of the formula I, | 08-13-2009 |
Nis Halland, Frankfurt Am Main DE
Patent application number | Description | Published |
---|---|---|
20130072493 | N-[4-(1H-PYRAZOLO[3,4-b]PYRAZIN-6-YL)-PHENYL]-SULFONAMIDES AND THEIR USE AS PHARMACEUTICALS - The present invention relates to N-[4-(1H-pyrazolo[3,4-b]pyrazin-6-yl)-phenyl]-sulfonamides of the formula I, | 03-21-2013 |
20140288083 | N-[4-(1H-PYRAZOLO[3,4-B]PYRAZIN-6-YL)-PHENYL]-SULFONAMIDES AND THEIR USE AS PHARMACEUTICALS - The present invention relates to N-[4-(1H-pyrazolo[3,4-b]pyrazin-6-yl)-phenyl]-sulfonamides of the formula I, | 09-25-2014 |
20140357640 | N-[4-(1H-PYRAZOLO[3,4-B]PYRAZIN-6-YL)-PHENYL]-SULFONAMIDES AND THEIR USE AS PHARMACEUTICALS - The present invention relates to N-[4-(1H-pyrazolo[3,4-b]pyrazin-6-yl)-phenyl]-sulfonamides of the formula (I), (R2)n wherein Ar, R1, R2 and n have the meanings indicated in the claims. The compounds of the formula (I) are valuable pharmacologically active compounds which modulate protein kinase activity, specifically the activity of serum and glucocorticoid regulated kinase (SGK), in particular of serum and glucocorticoid regulated kinase isoform 1 (SGK-1, SGK1), and are suitable for the treatment of diseases in which SGK activity is inappropriate, for example degenerative joint disorders or inflammatory processes such as osteoarthritis or rheumatism. The invention furthermore relates to processes for the preparation of the compounds of the formula (I), their use as pharmaceuticals, and pharmaceutical compositions comprising them. | 12-04-2014 |